Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

<p>Abstract</p> <p>Background</p> <p>Several recent studies have shown that angiotensin type 1 receptor (AT1) antagonists such as candesartan inhibit the microglial inflammatory response and dopaminergic cell loss in animal models of Parkinson's disease. However, t...

Full description

Bibliographic Details
Main Authors:	Garrido-Gil Pablo, Joglar Belen, Rodriguez-Perez Ana I, Guerra Maria J, Labandeira-Garcia Jose L
Format:	Article
Language:	English
Published:	BMC 2012-02-01
Series:	Journal of Neuroinflammation
Subjects:	Angiotensin AT1 neuroinflammation neuroprotection microglia Parkinson peroxisome proliferator-activated receptor gamma telmisartan
Online Access:	http://www.jneuroinflammation.com/content/9/1/38

Similar Items

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
by: Maksimov M.L., et al.
Published: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
by: M L Maksimov, et al.
Published: (2017-03-01)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
by: Ayza MA, et al.
Published: (2020-10-01)

Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
by: Ivona Yanovna Yarek-Martynova, et al.
Published: (2010-06-01)

Telmisartan, an Antagonist of Angiotensin II Receptors, Accentuates Voltage-Gated Na+ Currents and Hippocampal Neuronal Excitability
by: Ming-Chi Lai, et al.
Published: (2020-09-01)

Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats
by: Chang Ho Lee, et al.
Published: (2021-11-01)

Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
by: Begoña Villar-Cheda, et al.
Published: (2012-08-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism
by: Bipul Ray, et al.
Published: (2021-08-01)

An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release
by: Sigal Fleisher-Berkovich, et al.
Published: (2023-11-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARγ
by: Tao Liu, et al.
Published: (2021-09-01)

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
by: Jose L. Labandeira-Garcia, et al.
Published: (2017-05-01)

Angiotensin receptor blockers: rational prescription tailored to the cardiovascular risk and comorbidities
by: V. I. Podzolkov, et al.
Published: (2018-12-01)

Chronic Lithium Toxicity in Old Age Patients Taking Angiotensin Receptor Blocker: A Case Report
by: Asim Pandey, et al.
Published: (2023-11-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Telmisartan Protects Mitochondrial Function, Gait, and Neuronal Apoptosis by Activating the Akt/GSK3β/PGC1α Pathway in an MPTP-Induced Mouse Model of Parkinson's Disease
by: Bipul Ray, et al.
Published: (2024-02-01)

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
by: Rodolfo Pedro Rothlin, et al.
Published: (2021-03-01)

Telmisartan and cardioprotection
by: McFarlane S
Published: (2011-11-01)

Perspectives of using angiotensin receptor antagonists
by: V V Fomin
Published: (2009-06-01)

Angiotensin-(1-7) and Mas receptor in the brain
by: Natalia L. Rukavina Mikusic, et al.
Published: (2021-06-01)

Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
by: Zheng RH, et al.
Published: (2019-08-01)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
by: JungMin Choi, et al.
Published: (2021-09-01)

Neuroprotection in Stroke—Focus on the Renin-Angiotensin System: A Systematic Review
by: Sebastian Andone, et al.
Published: (2022-03-01)

Efficacy and safety of telmisartan monotherapy in the black hypertensive patient at a tertiary centre in Eastern Nigeria
by: C K Ijoma, et al.
Published: (2011-01-01)

The impact of peroxisome proliferator‐activated receptor‐γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy
by: Cho‐Han Chiang, et al.
Published: (2023-04-01)

Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
by: Hyun Woo Lee, et al.
Published: (2023-03-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)

The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice
by: Laura Nickel, et al.
Published: (2022-03-01)

The potential anticancer activities of telmisartan – a literature review
by: Andriana Hadjiyianni, et al.
Published: (2023-09-01)

The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open Label Study
by: Suresh V Sagarad, et al.
Published: (2014-04-01)

Efecto de telmisartan sobre marcadores del remodelado óseo en pacientes hipertensos Telmisartan effect's on remodelling bone markers in hypertensive patients
by: J. L. Pérez-Castrillón, et al.
Published: (2012-02-01)

Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model
by: Dong Geun Hong, et al.
Published: (2022-09-01)

Comparative Study of High Dose Mono-Therapy of Amlodipine or Telmisartan, and Their Low Dose Combination in Mild to Moderate Hypertension
by: Jaswant Goyal, et al.
Published: (2014-06-01)

A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
by: Plavnik Frida Liane, et al.
Published: (2002-01-01)

Immune pleiotropic effect of telmisartan in arterial hypertension
by: N. M. Agarkov, et al.
Published: (2022-07-01)

Diverse coactivator recruitment through differential PPARγ nuclear receptor agonism
by: Fernando Lizcano, et al.
Published: (2013-01-01)

Diverse coactivator recruitment through differential PPARγ nuclear receptor agonism
by: Fernando Lizcano, et al.
Published: (2013-01-01)

Understanding the pH Dependence of Supersaturation State—A Case Study of Telmisartan
by: Szabina Kádár, et al.
Published: (2022-08-01)